MXCT
MaxCyte, Inc. · Healthcare
Casdin Partners Master Fund, L.P. bought $23.4M of MaxCyte, Inc.
10% owner
Bought$23,400,000
$13.00Price
1,800,000Shares
+15%Stake
What MXCT did for a copier
Prices for MXCT after this filing aren't in yet.
Casdin Partners Master Fund, L.P.'s record
19 other buys with 3 months of prices since 2020: on average −9.4% against the S&P 500, and 7 of 19 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Jul 30. Filed Tue, Aug 3, 2:08 PM ET, during the session. Not investment advice.